On the contrary, co-treatment was found to show lower cytotoxicity towards normal human cells, which suggests that the strategy of DSeA in combination with TRAIL possesses great selectivity between cancer and normal cells and displays application potential in cancer chemoprevention and chemotherapy. This evidence concerns the gene TNFSF10 and cancer.